Marksans PharmaMARKSANS 
$3.20-1.87%24h
-1.87%24h
Global rank6327
Market cap$1.33B
Change 7d1.30%
YTD Performance64.95%
SP500 benchmarkOutperform
P/E0.50
P/S6.02
Revenue$220.50M
Earnings$31.63M
Dividend yield-
Main Sector
Healthcare
Category
Marksans Pharma (MARKSANS) Cash on Hand
MARKSANS Cash on Hand in 2022: $85.25M
According to Marksans Pharma latest financial reports the cash on hand of MARKSANS is $85.25M, an increase of 106.26% to 2022. At the end of 2022 company had $41.33M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
MARKSANS Cash on Hand History from 2019 to 2023
-
Value:-
MARKSANS Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $85.25M | 106.26% |
| 2022 | $41.33M | 65.46% |
| 2021 | $24.98M | 125.02% |
| 2020 | $11.10M | 183.43% |
| 2019 | $3.92M | - |
View the Top Cash on Hand Companies 
